Trials that use: P-values
New to this method? Read the tutorial →
20,601 results
- Modified Immune Cells (AFM13-NK) and A Monoclonal Antibody (AFM13) in Treating Patients With Recurrent or Refractory CD30 Positive Hodgkin or Non-Hodgkin Lymphomas: Complete Statistical AnalysisIndependent statistical analysis of Modified Immune Cells (AFM13-NK) and A Monoclonal Antibody (AFM13) in Treating Patients With Recurrent or Refractory CD30 Positive Hodgkin or Non-Hodgkin Lymphomas: primary endpoint results, effect estimate with…
- Modified Instrumentation for Surgery to Correct Trichiasis: Complete Statistical AnalysisIndependent statistical analysis of Modified Instrumentation for Surgery to Correct Trichiasis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00886015).
- Modified Process Hepatitis B Vaccine in Japanese Young Adults (V232-062): Complete Statistical AnalysisIndependent statistical analysis of Modified Process Hepatitis B Vaccine in Japanese Young Adults (V232-062): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01463683).
- Modified Reporting From Indwelling Catheters: Complete Statistical AnalysisIndependent statistical analysis of Modified Reporting From Indwelling Catheters: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03488355).
- Modified VR-CAP and Acalabrutinib as First Line Therapy for the Treatment of Transplant-Eligible Patients With Mantle Cell Lymphoma: Complete Statistical AnalysisIndependent statistical analysis of Modified VR-CAP and Acalabrutinib as First Line Therapy for the Treatment of Transplant-Eligible Patients With Mantle Cell Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Modifying (Phase I) and Evaluating (Phase II) Virtual Reality Job Interview Training for Youth in Transition: Complete Statistical AnalysisIndependent statistical analysis of Modifying (Phase I) and Evaluating (Phase II) Virtual Reality Job Interview Training for Youth in Transition: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Modifying Cervical Bishop Scoring System: Complete Statistical AnalysisIndependent statistical analysis of Modifying Cervical Bishop Scoring System: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02314260).
- Modifying Physical Activity and Sedentary Time in Filipino Faith Leaders: Complete Statistical AnalysisIndependent statistical analysis of Modifying Physical Activity and Sedentary Time in Filipino Faith Leaders: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03439852).
- ModOSAIndependent statistical analysis of Evaluation of Modafinil vs Placebo for Treatment of Anesthesia Delayed Emergence in Obstructive Sleep Apnea: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- MODULA Modul 7 VRR: Complete Statistical AnalysisIndependent statistical analysis of MODULA Modul 7 VRR: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00180414).
- Modular Study to Evaluate CT7001 Alone in Cancer Patients With Advanced Malignancies: Complete Statistical AnalysisIndependent statistical analysis of Modular Study to Evaluate CT7001 Alone in Cancer Patients With Advanced Malignancies: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Modulation of Human Myocardial Metabolism by GLP-1 Dose Response: Complete Statistical AnalysisIndependent statistical analysis of Modulation of Human Myocardial Metabolism by GLP-1 Dose Response: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01607450).
- Modulation of Pharmacologically Induced Alcohol Craving in Recently Detoxified Alcoholics: Complete Statistical AnalysisIndependent statistical analysis of Modulation of Pharmacologically Induced Alcohol Craving in Recently Detoxified Alcoholics: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00605904).
- Modulation of Sensory Acuity With Transcranial Magnetic Stimulation (TMS): Complete Statistical AnalysisIndependent statistical analysis of Modulation of Sensory Acuity With Transcranial Magnetic Stimulation (TMS): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05723575).
- MOHELIndependent statistical analysis of T Cell Depletion for Recipients of HLA Haploidentical Related Donor Stem Cell Grafts: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Molecular and Functional PET-fMRI Measures of Analgesia in Migraine: Complete Statistical AnalysisIndependent statistical analysis of Molecular and Functional PET-fMRI Measures of Analgesia in Migraine: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01970943).
- Molecular Guided Therapy for Refractory or Recurrent Neuroblastoma: Complete Statistical AnalysisIndependent statistical analysis of Molecular Guided Therapy for Refractory or Recurrent Neuroblastoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01355679).
- Molecular Profiling in Lung Cancer Patients: Complete Statistical AnalysisIndependent statistical analysis of Molecular Profiling in Lung Cancer Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00191308).
- Molecular-Guided Therapy for Childhood Cancer: Complete Statistical AnalysisIndependent statistical analysis of Molecular-Guided Therapy for Childhood Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02162732).
- Molecularly Determined Treatment of Diffuse Intrinsic Pontine Gliomas (DIPG): Complete Statistical AnalysisIndependent statistical analysis of Molecularly Determined Treatment of Diffuse Intrinsic Pontine Gliomas (DIPG): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01182350).
- MOLTIndependent statistical analysis of Mechanisms of Light-based Therapies for Dry Eye Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06004895).
- MOMSIndependent statistical analysis of Management of Myelomeningocele Study (MOMS): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00060606).
- MOMsIndependent statistical analysis of Medication Treatment for Opioid Use Disorder in Expectant Mothers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03918850).
- Mona LisaIndependent statistical analysis of Clinical Evaluation of the GLYDe Dressing for Post-surgical Incision Care: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00766727).
- MONALEESA-2Complete statistical analysis of MONALEESA-2, the randomized phase 3 trial of ribociclib plus letrozole versus placebo plus letrozole in postmenopausal women with advanced or metastatic breast cancer.
- MONALEESA-2Independent statistical analysis of Study of Efficacy and Safety of LEE011 in Postmenopausal Women With Advanced Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- MONALEESA-7Independent statistical analysis of MONALEESA-7, a randomized phase 3 trial of ribociclib plus endocrine therapy and goserelin versus placebo plus endocrine therapy and goserelin in premenopausal women with hormone receptor-positive, HER2-negative advanced…
- MONANTIIndependent statistical analysis of Monitoring Anti-Dementia Drugs by Serum Levels: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04117178).
- MONARCHIndependent statistical analysis of Caterpillar™ Arterial Embolization Device Post-Market Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04244370).
- MONARCH 1Independent statistical analysis of A Study of Abemaciclib (LY2835219) In Participants With Previously Treated Breast Cancer That Has Spread: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- MONARCH 3Independent statistical analysis of the phase 3 MONARCH 3 trial of abemaciclib plus a nonsteroidal aromatase inhibitor in postmenopausal women with breast cancer, including progression-free survival, response, health-status outcomes, methodology, safety, and…
- MONARCH plusIndependent statistical analysis of A Study of Abemaciclib (LY2835219) in Participants With Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02763566).
- Monitoring of Exhaled Carbon Monoxide to Promote Pre-operative Smoking Cessation: Complete Statistical AnalysisIndependent statistical analysis of Monitoring of Exhaled Carbon Monoxide to Promote Pre-operative Smoking Cessation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01014455).
- Monitoring of Symptoms and Cognitive Function Using Telehealth: Complete Statistical AnalysisIndependent statistical analysis of Monitoring of Symptoms and Cognitive Function Using Telehealth: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03184701).
- Monocentric Randomized Study, Assessing the Interests of the Determination of Vitamin D in Prison Population. (Vitamine D): Complete Statistical AnalysisIndependent statistical analysis of Monocentric Randomized Study, Assessing the Interests of the Determination of Vitamin D in Prison Population. (Vitamine D): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Monoclonal Antibody 3F8 and Sargramostim in Treating Patients With Neuroblastoma: Complete Statistical AnalysisIndependent statistical analysis of Monoclonal Antibody 3F8 and Sargramostim in Treating Patients With Neuroblastoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00072358).
- Monoclonal Antibody Ch14.18, Sargramostim, Aldesleukin, and Isotretinoin After Autologous Stem Cell Transplant in Treating Patients With Neuroblastoma: Complete Statistical AnalysisIndependent statistical analysis of Monoclonal Antibody Ch14.18, Sargramostim, Aldesleukin, and Isotretinoin After Autologous Stem Cell Transplant in Treating Patients With Neuroblastoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Monoclonal Antibody Therapy in Treating Patients Scheduled for Surgery to Remove Ovarian Cancer: Complete Statistical AnalysisIndependent statistical analysis of Monoclonal Antibody Therapy in Treating Patients Scheduled for Surgery to Remove Ovarian Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Monocyte Biomarkers in Moderate to Severe Plaque Psoriasis Subjects Treated With Apremilast: Complete Statistical AnalysisIndependent statistical analysis of Monocyte Biomarkers in Moderate to Severe Plaque Psoriasis Subjects Treated With Apremilast: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Monocyte Priming When Consuming a Western Diet: Complete Statistical AnalysisIndependent statistical analysis of Monocyte Priming When Consuming a Western Diet: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05348395).
- Monotherapy Brexpiprazole (OPC-34712) Trial in the Treatment of Adults With Early-Episode Schizophrenia: Complete Statistical AnalysisIndependent statistical analysis of Monotherapy Brexpiprazole (OPC-34712) Trial in the Treatment of Adults With Early-Episode Schizophrenia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Monotherapy Pazopanib in Subjects With Advanced Non-Small Cell Lung Cancer: Complete Statistical AnalysisIndependent statistical analysis of Monotherapy Pazopanib in Subjects With Advanced Non-Small Cell Lung Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00549328).
- Monotherapy Study of MP-513 in Patients With Type 2 Diabetes: Complete Statistical AnalysisIndependent statistical analysis of Monotherapy Study of MP-513 in Patients With Type 2 Diabetes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00998881).
- MONOVISC for Hip Joint Pain Relief Due to Osteoarthritis: Complete Statistical AnalysisIndependent statistical analysis of MONOVISC for Hip Joint Pain Relief Due to Osteoarthritis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04204083).
- Montelukast in Mild Asthmatic Children With Allergic Rhinitis (0476-367): Complete Statistical AnalysisIndependent statistical analysis of Montelukast in Mild Asthmatic Children With Allergic Rhinitis (0476-367): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00442559).
- Montelukast in Perennial Allergic Rhinitis – 2001-2002 Study (0476-246): Complete Statistical AnalysisIndependent statistical analysis of Montelukast in Perennial Allergic Rhinitis - 2001-2002 Study (0476-246): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00974571).
- Montelukast Therapy on Alzheimer’s Disease: Complete Statistical AnalysisIndependent statistical analysis of Montelukast Therapy on Alzheimer's Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03991988).
- Monthly And Twice Monthly Subcutaneous Dosing Of PF-04950615 (RN316) In Hypercholesterolemic Subjects On A Statin: Complete Statistical AnalysisIndependent statistical analysis of Monthly And Twice Monthly Subcutaneous Dosing Of PF-04950615 (RN316) In Hypercholesterolemic Subjects On A Statin: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- MoodStimIndependent statistical analysis of Home-based tDCS in Major Depressive Disorder: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04799405).
- MOPACIndependent statistical analysis of Management Of Pain After Cesarean Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03929640).